Seems like every year, Black Friday gets a little earlier. Sure, people typically say that about Christmas. But who can think ...

These new challengers are anticipated to account for roughly $70 billion of the total GLP-1 market, which is expected to be worth $200 billion by 2031. Our report on the obesity drug market ...

Novo Nordisk has partnered with Ascendis Pharma on less frequently dosed drugs for obesity and other metabolic diseases, starting with a once-monthly GLP-1 receptor agonist. The Danish pharma ...

Earlier this month, the FDA put out a statement saying that it, too, was concerned about patients and healthcare professionals turning to unapproved versions of GLP-1 drugs as an option for weight ...

SHOPPING: If you're ready to take control of your weight loss goals, turn to Get Thin MD for prescription GLP-1 medications that can help you achieve the body of your dreams. SHOPPING: Save up to ...